Butterfield D Allan
Sanders-Brown Center on Aging, Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA.
Antioxidants (Basel). 2023 Feb 11;12(2):462. doi: 10.3390/antiox12020462.
Amnestic mild cognitive impairment (MCI), arguably the earliest clinical stage of Alzheimer disease (AD), is characterized by normal activities of daily living but with memory issues but no dementia. Oxidative stress, with consequent damaged key proteins and lipids, are prominent even in this early state of AD. This review article outlines oxidative stress in MCI and how this can account for neuronal loss and potential therapeutic strategies to slow progression to AD.
遗忘型轻度认知障碍(MCI)可以说是阿尔茨海默病(AD)最早的临床阶段,其特征是日常生活活动正常,但存在记忆问题且无痴呆。即使在AD的这个早期阶段,氧化应激以及随之而来的关键蛋白质和脂质受损也很突出。这篇综述文章概述了MCI中的氧化应激,以及它如何导致神经元丧失,还介绍了减缓向AD进展的潜在治疗策略。